Viewing Study NCT00800956


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-02-23 @ 4:10 AM
Study NCT ID: NCT00800956
Status: COMPLETED
Last Update Posted: 2011-04-07
First Post: 2008-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study to Determine the Absorption, Distribution, Metabolism and Excretion of Esreboxetine
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Radiolabel ADME study Healthy volunteers View